BSN — BrainScan SA Income Statement
0.000.00%
- PLN37.18m
- PLN36.89m
- PLN0.21m
Annual income statement for BrainScan SA, fiscal year end - December 31st, PLN millions except per share, conversion factor applied.
2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|
Period Length: | 12 M | 12 M | 12 M |
Source: | ARS | ARS | PRESS |
Standards: | PAS | PAS | — |
Status: | Final | Final | Final |
Revenue | |||
Total Revenue | 0.095 | 0.056 | 0.214 |
Cost of Revenue | |||
Gross Profit | 0.048 | -0.065 | 0.097 |
Selling / General / Administrative Expenses | |||
Depreciation and Amortization | |||
Other Operating Expenses | |||
Total Operating Expenses | 1.47 | 2.16 | 5.01 |
Operating Profit | -1.37 | -2.11 | -4.8 |
Total Net Non Operating Interest Income / Expense | |||
Other Net Non Operating Costs | |||
Net Income Before Taxes | -1.37 | -2.09 | -4.77 |
Provision for Income Taxes | |||
Net Income After Taxes | -1.37 | -1.79 | -5.07 |
Net Income Before Extraordinary Items | |||
Net Income | -1.37 | -1.79 | -5.07 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||
Income Available to Common Shareholders Including Extraordinary Items | |||
Diluted Net Income | -1.37 | -1.79 | -5.07 |
Diluted Weighted Average Shares | |||
Basic EPS Including Extraordinary Items | |||
Diluted EPS Including Extraordinary Items | |||
Diluted EPS Excluding Extraordinary Items | |||
Normalised Income Before Taxes | |||
Normalised Income After Taxes | |||
Normalised Income Available to Common Shareholders | |||
Diluted Normalised EPS | -1.18 | -1.53 | -4.34 |